Cost-utility of NeuroSAFE-guided RARP Versus Standard RARP in Men with Localised Prostate Cancer in the UK

医学 前列腺切除术 前列腺癌 勃起功能障碍 金标准(测试) 经济评价 小心等待 泌尿科 妇科 梅德林 缺少数据 前列腺 人口 病态的 时间范围 成本效益分析 质量调整寿命年 地平线 成本效益 风险评估
作者
Jiunn Wang,Ricardo Almeida-Magaña,Eoin P. Dinneen,Shengning Pan,Baptiste Leurent,Nicholas J. Roberts,Chris Brew‐Graves,Norman R. Williams,Aiman Haider,Greg L. Shaw,Elena Pizzo
出处
期刊:European urology open science [Elsevier BV]
卷期号:92: 55-63
标识
DOI:10.1016/j.euros.2026.08.007
摘要

Background: Robotic radical prostatectomy (RARP) is a standard first-line curative treatment for localised prostate cancer but carries risks of erectile dysfunction and urinary incontinence. The NeuroSAFE technique provides pathological assessment to optimise nerve-sparing whilst avoiding positive surgical margins. Objective: This study evaluated the cost-effectiveness of NeuroSAFE-guided RARP compared with standard RARP. Design setting and participants: A within-trial economic evaluation with a 12-month time horizon was conducted alongside NeuroSAFE-PROOF, a single-blinded, multi-centre, randomised controlled trial. Participants were patients with a diagnosis of non-metastatic prostate cancer deemed suitable to undergo RARP, good erectile function without medical erectile function assistance, and no previous prostate cancer treatment. No age limits were applied. Intervention: The intervention is the NeuroSAFE-guided RARP. Outcome measurements and statistical analysis: Costs were assessed from NHS and societal perspectives using patient-level data. Quality-adjusted life years (QALYs) were measured using EQ-5D-5L. Incremental cost-effectiveness ratios (ICERs) and net monetary benefits were estimated. Uncertainty was captured via bootstrapping, missing data were addressed through multiple imputation, and Monte Carlo simulations were undertaken to assess robustness. Results and limitations: Among 407 randomised patients (NeuroSAFE: 204; standard RARP: 203), NeuroSAFE increased mean total cost (by £827 and £1,000 from NHS and societal perspectives, respectively) and QALYs (by 0.03). ICERs were £26,195/QALY (NHS) and £31,666/QALY (societal). Cost-effectiveness probabilities were 53% and 56% (NHS) and 48% and 56% (societal) at the lower and upper UK willingness-to-pay thresholds. Limitations include substantial uncertainty around estimates, missing data, and potential recall bias from retrospectively collected data. Findings reflect short-term, within-trial estimates and should be interpreted accordingly. Conclusions and Patient summary: NeuroSAFE-guided RARP increased costs and generated modest QALY gains on average. ICERs were within the upper UK threshold, although substantial uncertainty remained. These findings reflect 12-month within-trial economic outcomes and should not be interpreted as evidence of long-term cost-effectiveness.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
斯文如娆发布了新的文献求助30
1秒前
只争朝夕的应助被可妍昇采纳,获得10
1秒前
1秒前
CipherSage的应助被qyt采纳,获得10
2秒前
2秒前
2秒前
2秒前
奋斗若风完成签到,获得积分10
4秒前
zjq4302完成签到,获得积分10
4秒前
ZZZZZZZZ完成签到,获得积分10
4秒前
4秒前
XINGCHEN完成签到 ,获得积分10
4秒前
5秒前
5秒前
Xxxy完成签到 ,获得积分10
5秒前
5秒前
6秒前
wjw完成签到,获得积分10
7秒前
风信子完成签到,获得积分10
7秒前
7秒前
7秒前
苏丽妃完成签到 ,获得积分10
7秒前
情怀的应助被jc哥采纳,获得10
7秒前
Zz发布了新的文献求助20
7秒前
Elige完成签到,获得积分10
7秒前
孙淳完成签到,获得积分10
7秒前
yan发布了新的文献求助10
7秒前
所所的应助被liquidwy采纳,获得10
8秒前
汉堡包的应助被白白采纳,获得10
8秒前
俞佳美发布了新的文献求助10
8秒前
ylva完成签到,获得积分10
8秒前
plemon完成签到,获得积分10
9秒前
圆圆完成签到,获得积分10
9秒前
unqiue的应助被荼蘼采纳,获得10
9秒前
元吉的应助被荼蘼采纳,获得10
9秒前
Ximilu发布了新的文献求助10
9秒前
我是老大的应助被荼蘼采纳,获得10
9秒前
heady发布了新的文献求助10
9秒前
明理的千筹发布了新的文献求助100
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180927
求助须知:如何正确求助?哪些是违规求助? 9570973
关于积分的说明 21815578
捐赠科研通 7777227
什么是DOI,文献DOI怎么找? 3433367
关于科研通互助平台的介绍 2557621
邀请新用户注册赠送积分活动 2479346